Rus BioPharm was founded in 2012, as an Integrated full-cycle BioPharmaceutical Company with a focus on: - Biological Products and Biosimilars - Innovative Drugs - Targeted Therapy Drugs Rus BioPharm is focused on manufacturing of complex generics and biosimilars for severe diseases, including orphan indications. Rus BioPharm is actively developing new products, including high value generics and biosimilars and is in constant search of products for co-development and in-licencing, primarily for Russia and CIS market.